The concentration of ascorbic acid in different tissues of calf fetuses in 3 different development stages]

The concentration of ascorbic acid in the cerebrum and in the brain stem of bovine fetuses decreased with increasing body weight; in the cerebellum there was no change. The decrease of the concentration in the lungs, in the heart, in the kidneys, in the M. longissimus and in the M. semimembranosus in the course of the fetal growth was different. In the liver and in the adrenals the concentration in the 3 groups of fetuses with a body weight of 4.18 +/- 2.01, of 9.72 +/- 0.97 and of 17.12 +/- 2.61 kg was similar. The highest concentrations were found in the adrenals, in the testes and in the cerebrum. The functional significance of the changes in the concentration in the tissues of the bovine fetuses is discussed and compared with the results in human fetuses and in adult cattle.     

Effects of dietary supplemental L-carnitine and ascorbic acid on performance, carcass composition and plasma L-carnitine concentration of broiler chicks reared under different temperature.

The present study was initiated to determine whether dietary supplemental L-carnitine and ascorbic acid affect growth performance, carcass yield and composition, abdominal fat and plasma L-carnitine concentration of broiler chicks reared under normal and high temperature. During the experiment, two temperature regimes were employed in two experimental rooms, which were identical but different in environmental temperature. The regimes were thermoneutral (20-22 degrees C for 24 h) or recycling hot (34-36 degrees C for 8 h and 20-22 degrees C for 16 h). One-day-old broiler chicks (ROSS) were used in the experiment. A 2 x 2 x 2 factorial arrangement was employed with two levels (0 and 50 mg/kg) of supplemental L-carnitine and two levels (0 or 500 mg/kg) of supplemental ascorbic acid in drinking water under thermoneutral or high temperature regimes. Body weight gain was affected by high temperature. However, body weight gain was significantly improved in animals receiving supplemental L-carnitine, ascorbic acid or L-carnitine + ascorbic acid compared to animals receiving unsupplemented diet under high temperature. On the other hand, supplemental L-carnitine or L-carnitine + ascorbic acid reduced body weight gain under thermoneutral condition. Supplemental ascorbic acid significantly improved feed conversion efficiency, the improvement was relatively greater under high temperature. The L-carnitine content in the plasma was higher in the groups receiving supplemental L-carnitine and ascorbic acid under high temperature, while broilers fed supplemental L-carnitine and ascorbic acid had a decreased level of plasma L-carnitine concentration under normal temperature. It is concluded that dietary supplemental L-carnitine or L-carnitine + ascorbic acid may have positive effects on body weight gain, carcass weight under high temperature conditions.     

Effect of chronic infusion of placental lactogen on ovine fetal growth in late gestation

To test the hypothesis that placental lactogen (PL) is a Immoral regulator of fetal growth, six singleton sheep fetuses received a continuous intravenous fusion of 1.2 mg/d of purified ovine PL (oPL) for 14 d, beginning on Day 122 of gestation. The plasma concentration of oPL was approximately four-fold higher in infused fetuses than in six control fetuses that received a continuous infusion of saline. The circulating insulin-like growth factor 1 (IGF-1) concentration was also significantly elevated in PL-infused fetuses (43.1 ± 1.7 vs. 31.9 ± 4.l ng/ml; P < 0.05). Animals were slaughtered on Day 136, and the placenta and all major fetal tissues were dissected, weighed, and subsampled for chemical analysis. Fetal weight and crown-rump length were not significantly affected by treatment; however, the aggregate weight of the brain, liver, lungs, and heart tended to be larger (85.3 ± 2.1 vs. 79.9 ± 1.5 g/kg fetus; mean ± SE, P = 0.07) and the thyroid gland was smaller (0.18 ± 0.l vs. 0.26 ± 0.02 g/kg fetus; P < 0.05) in the PL-infused fetuses. The livers of the PL-infused fetuses had also accumulated additional glycogen (13.1 ± l.7 vs. 8.4 ± 0.7 g; P < 0.05). In late gestation, PL within the fetal compartment increases fetal plasma IGF-1 concentration and hepatic glycogen deposition and may affect the growth of several vital organs.     

Placental transfer of etomidate in pregnant ewes after an intravenous bolus dose and continuous infusion

Etomidate (ETO) is a short-acting intravenous (IV) anaesthetic characterised by cardiopulmonary stability and favourable pharmacokinetics. Although ETO has been used satisfactorily in obstetrical anaesthesia, little is known about placental transfer and the drug's pharmacokinetics in the fetus. Placental transfer in pregnant ewes has been evaluated following the administration of an IV bolus of 1mg/kg ETO; and after a 1-h infusion of 100 microg/kg min(-1) ETO preceded by an IV bolus of 1mg/kg. In ewes, ETO concentration and AUC were higher than those found in fetuses. After the ETO bolus dose, the fetus:ewe AUC ratio was 0.45+/-0.32, and the mean residence time (MRT) was 20+/-7 min for dams and 22+/-3 min for the fetuses. After ETO infusion, the AUC ratio was 0.37+/-0.08, and MRT was 46+/-12 min for ewes and 46+/-22 min for fetuses. Although ETO crosses the placenta very rapidly and reaches the fetus in high amounts, a certain placental barrier effect limits its transfer. There is no evidence of cumulative effects of the drug in the fetus as fetal ETO elimination was as rapid as in the dam.     

Conceptus and maternal responses to increased feed intake during early gestation in pigs

Maternal diet influences fetal growth and postnatal development. We hypothesized that conceptuses gestated in sows provided ad libitum vs. restricted feed intake would differ in the milieu of hormones, growth factors, nutrients, and metabolites associated with growth and metabolism. This hypothesis was tested in two experiments by providing fourth-parity sows (Pig Improvement Co. C15 bred to Line 326 boars) with either 1.81 kg/d (as-fed basis; control) or ad libitum access to gestation diet. In Exp. 1, control (n = 6) or ad libitum (6.4 +/- 0.11 kg/d; n = 9) treatments were provided from d 29 to 45 (onset of estrus is d 0), and sows were slaughtered on d 46. Ad libitum sows gained more weight from d 29 to 45 than controls (34.0 vs. 4.32 kg, respectively; P < 0.01). No differences were observed on d 46 for the number of fetuses, conceptus attachment length, allantoic + amniotic fluid volume, placental weight, fetal weight, and fetal crown-to-rump length. Variation in fetal crown-to-rump length was less (P < 0.03) in sows fed ad libitum. Sows fed ad libitum had greater (P < 0.01) IGF-I and insulin concentrations in plasma than controls on d 43. In Exp. 2, sows were fed 1.81 kg/d (n = 6) or ad libitum (7.0 +/- 0.11 kg/d; n = 4) from d 30 to 56 of gestation, when sows were anesthetized and samples were collected surgically from their gravid uteri. Sows fed ad libitum gained more weight (P < 0.01) than did controls and had more (P < 0.06) IGF-I in their plasma and the plasma collected from umbilical veins of their fetuses. No differences were found for concentrations of insulin or glucose in plasma of sows or fetuses, but urea N concentrations were greater (P < 0.05) in maternal plasma and in the plasma, and allantoic and amniotic fluids of conceptuses from sows fed ad libitum. Combined data from Exp. 1 and 2 revealed a treatment x fetal number interaction (P < 0.05) for average fetal weight. The expected negative relationship between within-litter average fetal weight and the number of fetuses per uterus was observed for control sows (y = 115.4 -1.75 x fetal number; P < 0.05), but litters of ad libitum sows did not show this effect. The hypothesis that providing feed in excess of established requirements in early gestation affects the in utero milieu is supported by these results. Data further reveal that, at least at mid-gestation, the restraint to fetal growth that is exhibited when fetal number increases in control sows is not exhibited when sows are fed ad libitum.     

沙拉沙星对大鼠生殖毒性和致畸性的研究

本文报道沙拉沙星对Wistar大鼠生殖毒性和致畸性的研究，在孕鼠妊娠经7－15d，分别经口灌服5、50和500mg/kg b.w.剂量沙拉沙星溶液。试验结果显示，沙拉沙星对孕鼠的健康状况、行为和增重均无明显影响；各剂量组受孕鼠的活胎数、死胎数和吸收胎数均无明显影响；除500mg/kg b.w.剂量组胎鼠的体长明显低于对照组外，各组间的胎鼠体重、体长、尾长和胎盘重均未见明显差异；各剂量组和对照组均未出现外观畸形和内脏畸形，仅500mg/kg b.w.剂量组胎鼠的骨骼畸形出现率（36.3%）显著高于对照组（8.7%），但不存在剂量－反应关系。作者认为沙拉沙星对Wistar大鼠无明显的生殖毒性和致畸性。     

The content of ascorbic acids in different tissues of cattle, normally developed piglets, splay-legged piglets, adult swine and dogs

The following ascorbic acid levels were recorded from different organs of cattle, with all values quoted being related to mg/100 g fresh matter: 150 +/- 20 in pituitary gland, 170 +/- 40 in left adrenal gland, 45.5 +/- 12.5 in spleen, 38.1 +/- 7.3 in liver, 30.0 +/- 8.5 in cerebrum, 23.2 +/- 7.2 in cerebellum, 16.4 +/- 6.1 in kidney, 11.0 +/- 2.9 in heart, and 9.1 +/- 2.1 in M. longissimus dorsi. The ascorbic acid level in blood plasma of normally developed piglets was 6.5 +/- 2.7 mg/dl and was thus higher with significance (p less than 0.01) than that recorded from splayleg piglets which was 2.3 +/- 0.96 mg/dl. The levels in the M. semimembranosus and M. semitendinosus in piglets of moderate birth weight were higher, as well (p less than 0.05). The liver level in pigs for slaughter was 30.8 +/- 9.0 mg/100 g lower than that in piglets. Piglets exhibited genetically founded differences in their capability of biosynthesis of ascorbic acid. The highest ascorbic acid level in dog was recorded from the pituitary and adrenal glands, values being 135.5 +/- 7.5 mg/100 g fresh matter or 90.3 +/- 37.8 mg/100 g. Their liver level was 27.9 +/- 11.9 mg/100 g.     

Influence of Dietary Ascorbic Acid on the Immune Responses of Juvenile Korean Rockfish Sebastes schlegelii

Juvenile Korean Rockfish Sebastes schlegelii (length, 13.6 ± 1.4 cm [mean ± SD]; weight, 53.6 ± 4.2 g) were fed twice daily with diets containing varying levels of ascorbic acid (0, 50, 100, 200, and 400 mg/kg) for 4 weeks. Significant increases in daily weight and length occurred in fish fed more than 50 mg/kg ascorbic acid. The lysozyme activity of fish fed diets containing ascorbic acid was considerably increased in rockfish plasma at 400 mg/kg ascorbic acid and in kidney at over 50 mg/kg ascorbic acid. Total plasma immunoglobulin M (IgM) levels were markedly elevated in fish fed 400 mg/kg ascorbic acid. The results suggest that dietary ascorbic acid supplementation in juvenile rockfish can induce a significant increase in growth and in immunological features such as lysozyme activity and plasma IgM levels.

Received October 1, 2014; accepted May 2, 2015     

Effects of supplemental ascorbic acid on performance, organ weight and plasma cholesterol concentration in broilers treated with propylthiouracil

1. Four experiments were conducted to determine if dietary ascorbic acid (AA) affects body weight gain, food intake, organ weights, plasma cholesterol concentration, and ascorbic acid concentration in the plasma and liver of growing male broilers treated with an antithyroidal agent, propylthiouracil (PTU). 2. In the first experiment, 15 mg AA was administered daily into the crop of chicks fed on a diet supplemented with or without PTU (500 mg/kg). Administration of AA reduced plasma cholesterol concentrations in the PTU-treated chicks. 3. In the other three experiments, chicks were given the basal diet or an AA-containing (3 g/kg) diet supplemented with or without PTU (250 mg or 500 mg/kg). Feeding AA partly prevented the decreases in body weight gain, gain:food ratio and weights of the bursa of Fabricius and thymus in chicks fed on the 250 mg/kg PTU diet, and also prevented the increase in plasma cholesterol concentrations in chicks fed on the PTU diet. 4. These results suggest that AA improves the performance of chicks with experimentally induced hypothyroidism.     

Ultrasonographic monitoring of nuclear transferred fetal weight during the final stage of gestation in Holstein cows

Dystocia or stillbirth accompanied by Large Offspring Syndrome (LOS) occurs rather frequently in Holstein nuclear transferred calves. In regard to prophylaxes, nuclear transferred Holstein fetuses were monitored with ultrasonography during the final stage of gestation. Fetal weight was estimated weekly based on the fetal metacarpal width using ultrasonography. Fourteen Holstein cows pregnant with Holstein nuclear transferred fetuses were the subjects of this experiment. The fetal weight was estimated by measuring the fetal metacarpal width during the last month of gestation according to the expected date of parturition. Measurements were performed on a weekly basis. The ultrasound-estimated metacarpal width and body weight of 13 of the fetuses in the last week of gestation (30.2+/-2.2 mm, 50.0+/-4.7 kg) were similar to the actual measurement immediately after birth (30.0+/-2.1 mm, 51.2+/-5.5 kg). These results indicate that ultrasonographic monitoring within a week of parturition to is accurate for estimating fetal weight. Prediction of LOS with ultrasonography contributes to reliable a diagnostic method that minimizes syndrome-related gyneco-obstetric complications at parturition with the aid of appropriate treatments.     

Relations between maternal and fetal plasma concentrations of placental lactogen and placental and fetal weights in well-fed ewes

The concentration of ovine placental lactogen (oPL) in maternal plasma varies with litter size and nutritional status, making it difficult to compare these concentrations across studies. In this study, 27 Dorset and Finn-Dorset crossbred ewes with litters of known size and gestational age were used to relate concentrations of oPL in maternal plasma to placental and fetal weights. Fetal oPL concentrations also were correlated to these variables in 12 chronically catheterized singleton fetuses. The concentration of oPL in maternal plasma increased with increasing placental weight across litter sizes ranging from 1 to 3 (r = .716). When expressed per gram of placenta, oPL was greater (P less than .05) in those ewes carrying multiple fetuses. There was no correlation between maternal and fetal oPL in time-matched samples or in average values between individuals for ewes carrying singleton pregnancies. Within the singleton group, placental weight and fetal weight were well correlated (r = .761), as were the concentration of fetal plasma oPL and fetal weight (r = .699). Placental weight plus fetal oPL could explain 81% of the variation seen in fetal weight. These results imply that maternal and fetal oPL release are controlled independently and that fetal oPL affects fetal growth by a mechanism not directly related to placental size.     

Bioavailability and pharmacokinetics of florfenicol in broiler chickens

The bioavailability and pharmacokinetic disposition of florfenicol in broiler chickens were investigated after intravenous (i.v.), intramuscular (i.m.) and oral administrations of 15 and 30 mg/kg body weight (b.w.). Plasma concentrations of florfenicol were determined by a high performance liquid chromatographic method in which plasma samples were spiked with chloramphenicol as internal standard. Plasma concentration-time data after i.v. administration were best described by a two-compartment open model. The elimination half-lives were 168 +/- 43 and 181 +/- 71 min, total body clearance 1.02 +/- 0.17 and 1.02 +/- 0.16 L x kg/h, the volume of distribution at steady-state 4.99 +/- 1.11 and 3.50 +/- 1.01 L/kg after i.v. injections of 15 and 30 mg/kg b.w., respectively. Plasma concentration-time data after i.m. and oral administrations were adequately described by a one-compartment model. The i.m. bioavailability and the oral bioavailability of florfenicol were 95, 98 and 96, 94%, respectively, indicating that florfenicol was almost absorbed completely after i.m. and oral administrations of 15 and 30 mg/kg b.w.     

Plasma concentrations of folic acid, vitamin B12 and progesterone of cyclic bitches, bitches during pregnancy and induced abortion and bitches with pyometra

The aim of this study was to investigate the plasma concentrations of folic acid, vitamin B12 and progesterone at different stages of the sexual cycle and pregnancy, during induced abortion and in bitches with pyometra. Bitches (n = 97) were assigned to groups as follows: a) oestrous cycle (n = 42) b) pregnancy (n = 25) c) induction of abortion (n = 10 and d) pyometra (n = 20). Oestrous cycle stages were determined by vaginal inspection and cytology. Pregnancies were estimated by ultrasound (5.0 Mhz; linear transducer; Schimadzu) at days 15-25, 35-45 and 46-63 of pregnancy. Treatments for the induction of abortion were started between days 25 and 35 after mating (5 microg/kg cabergoline daily, Galastop; 5-10 microg/kg Alfaprostol every other day, Gabbrostim). Diagnosis of pyometra was confirmed by ultrasound and vaginoscopy. Folic acid and vitamin B12 concentrations did not differ among different stages of the oestrous cycle. The mean concentration of folic acid during early pregnancy (days 15-25) exceeded levels of later stages (days 46-63): 9.4 +/- 3.7 microg/ml and 4.7 +/- 1.8 microg/ml, respectively (p < 0.01). A positive correlation between folic acid and vitamin B12 was determined in pregnant dogs ( r = 0.925; p < 0.02). Before the induction of abortion, the concentration of folic acid was 9.6 +/- 5.2 microg/ml; during abortion it decreased to 5.0 +/- 3.2 microg/ml (p < 0.01). A significant correlation (r = 0.925; p < 0.02) between progesterone and folic acid was obtained in bitches with abortion. The mean concentration of folic acid in bitches with pyometra significantly differed from that of bitches at different stages of the oestrous cycle (p < 0.05). The mean concentration of folic acid was significantly lower in metoestrous bitches when compared to bitches with pyometra (p < 0.05). The decrease of serum concentrations of folic acid during pregnancy and induced abortion show that fetal growth and abortion caused higher consumption of folic acid. Concerning bitches did not show any deficiency symptoms, which is why it can be concluded that this decrease is physiological.     

Faecal excretion profile of moxidectin and ivermectin after oral administration in horses

A study was undertaken to evaluate and compare faecal excretion of moxidectin and ivermectin in horses after oral administration of commercially available preparations. Ten clinically healthy adult horses, weighing 390-446 kg body weight (b.w.), were allocated to two experimental groups. Group I was treated with an oral gel formulation of moxidectin at the manufacturer's recommended therapeutic dose of 0.4 mg/kg b.w. Group II was treated with an oral paste formulation of ivermectin at the recommended dose of 0.2 mg/kg b.w. Faecal samples were collected at different times between 1 and 75 days post-treatment. After faecal drug extraction and derivatization, samples were analysed by High Performance Liquid Chromatography using fluorescence detection and computerized kinetic analysis.For both drugs the maximum concentration level was reached at 2.5 days post administration. The ivermectin treatment groups' faecal concentrations remained above the detectable level for 40 days (0.6 +/- 0.3 ng/g), whereas the moxidectin treatment group remained above the detectable level for 75 days (4.3 +/- 2.8 ng/g). Ivermectin presented a faster elimination rate than moxidectin, reaching 90% of the total drug excreted in faeces at four days post-treatment, whereas moxidectin reached similar levels at eight days post-treatment. No significant differences were observed for the values of maximum faecal concentration (C(max)) and time of C(max)(T(max)) between both groups of horses, demonstrating similar patterns of drug transference from plasma to the gastrointestinal tract. The values of the area under the faecal concentration time curve were slightly higher in the moxidectin treatment group (7104 +/- 2277 ng.day/g) but were not significantly different from those obtained in the ivermectin treatment group (5642 +/- 1122 ng.day/g). The results demonstrate that although a 100% higher dose level of moxidectin was used, attaining higher plasma concentration levels and more prolonged excretion and gut secretion than ivermectin, the concentration in faeces only represented 44.3+/- 18.0% of the total parental drug administered compared to 74.3 +/- 20.2% for ivermectin. This suggests a higher level of metabolization for moxidectin in the horse.     

Streptozotocin-induced diabetes decreases placenta growth factor (PlGF) levels in rat placenta

The placenta produces several growth factors, including placenta growth factor (PlGF), which are essential for placenta growth and fetal growth. Diabetic pregnancy induces the abnormal placental growth and fetal development. This study investigated whether diabetes in pregnant rats induces changes in PlGF expression in the placenta. Diabetes was induced by a single intravenous injection of streptozotocin (35 mg/kg body weight) on day 0 of pregnancy, blood and tissue samples were collected on day 20 of pregnancy. In the diabetic group, maternal body weight and fetal weight significantly decreased compared to controls. RT-PCR and Western blot analyses showed that expression of PlGF was significantly decreased in placenta by streptozotocin treatment. Immunohistochemical study showed that the positive signal of PlGF in trophoblast cells was decreased in the diabetic group compared to controls. These findings demonstrate the decline of PlGF in the placenta in diabetic pregnancy.     

Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice

The enzyme 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD) catabolizes progesterone into a biologically inactive steroid, 20alpha-dihydroprogesterone (20alpha-OHP). In the corpora lutea of rats and mice, 20alpha-HSD is considered to be involved in functional luteolysis. It is also distributed in other tissues including the placenta, endometrial epithelia and fetal skin, although the roles it plays in these tissues remain to be elucidated. In the present study, we investigated the role of 20alpha-HSD in the maintenance of pregnancy using mice with targeted disruption of the 20alpha-HSD gene. We first confirmed that the number of pups was significantly smaller in 20alpha-HSD-/- pairs than in 20alpha-HSD+/+ pairs. We then mated 20alpha-HSD+/- males and females so that each pregnant female produced 20alpha-HSD+/+, 20alpha-HSD+/- and 20alpha-HSD-/- offspring. The genotype ratio of the offspring did not match the Mendel's law of inheritance, and the numbers of 20alpha-HSD+/- and 20alpha-HSD-/- offspring were smaller than expected values. Although the genotype ratio of fetuses on days 13, 15 and 18 of pregnancy matched the Mendel's law, the total number of fetuses on day 18 was significantly smaller than that on day 13, suggesting that fetal loss occurred during late pregnancy. Next, we transferred 20alpha-HSD+/+ embryos to 20alpha-HSD+/+ or 20alpha-HSD-/- females and found that the number of offspring was significantly smaller in 20alpha-HSD-/- dams than in 20alpha-HSD+/+ dams. Expression of 20alpha-HSD mRNA in the fetus, placenta and uterus progressively increased from day 11 to 18 of pregnancy. In addition, concentrations of progesterone were significantly higher in the 20alpha-HSD-/- fetuses than in the 20alpha-HSD+/+ fetuses, while those of 20alpha-OHP were lower in the 20alpha-HSD-/- fetuses than in the 20alpha-HSD+/+ fetuses. These results suggest that both maternal and fetal 20alpha-HSD play a role in maintaining normal pregnancy at least partially by reducing progesterone concentrations in fetuses.     

The effect of dietary restriction, pregnancy, and fetal type in different ewe types on fetal weight, maternal body weight, and visceral organ mass in ewes

Our objectives were to evaluate maternal body changes in response to dietary restriction or the increased nutrient requirement of fetal growth. In Exp. 1, 28 mature crossbred ewes (61.6 +/- 1.8 kg initial BW) were fed a pelleted forage-based diet to evaluate effects of pregnancy and nutrient restriction on visceral organ mass. Treatments were arranged in 2 x 3 factorially, with dietary restriction (60% restriction vs. 100% maintenance) and reproductive status (nonpregnant [NP], d 90 or d 130 of gestation) as main effects. Dietary treatments were begun at d 50 of gestation, and restricted ewes remained at 60% of maintenance throughout the experiment. Nonpregnant and d-90 ewes were fed dietary treatments for 40 d and slaughtered. The d-130 ewes were fed dietary treatments for 80 d and then slaughtered. In Exp. 2, four Romanov ewes were naturally mated (Romanov fetus and Romanov dam; R/ R), and two Romanov embryos were transferred to each of four Columbia recipients (Romanov embryos and Columbia recipient; R/C). Three Columbia ewes were naturally mated (Columbia fetus and Columbia recipient; C/C). In both experiments, maternal organ weights were reported as fresh weight (grams), scaled to empty body weight (EBW; grams per kilogram) and maternal body weight (MBW; grams per kilogram). In Exp. 1, ewe EBW and fetal mass were decreased (P < 0.02) with restriction compared with maintenance. Dietary restriction decreased liver mass (16.7 vs. 14.5 g/kg EBW or 18.8 vs. 16.4 g/kg MBW; P < 0.01), but dietary restriction did not affect total digestive tract mass. In Exp. 2, ewe BW was less for the R/R compared with R/C and C/C (44.8 vs. 110.4 and 98.1 +/- 7.9 kg, respectively; P < 0.01). Fetal weight at d 130 was less for the R/R than for R/C and C/C (2.2 vs. 3.3 and 4.7 +/- 0.3 kg, respectively; P < 0.01) when measured as individual fetuses; however, when measured as total fetal mass carried in each ewe, there was no effect of ewe type. These data suggest that the gastrointestinal tract, along with other maternal organs, responds to both level of dietary intake and nutrient requirements for gestation, and that fetal weight is decreased as a result of a 40% decrease in nutrients offered.     

Effect of dietary vitamin A, ascorbic acid and their interaction on turkey bone mineralisation.

At early ages, added dietary ascorbic acid did not affect growth or femur mineralisation of poults. In poults after 8 and 12 weeks, femur mass was reduced by 3000 mg ascorbic acid per kg diet. 2. Plasma calcium and magnesium were not influenced differently by 1000, 4000 and 16,000 IU vitamin A/kg diet, but plasma phosphorus was decreased by the 16,000 level. 3. Vitamin A at 1000 or 16,000 IU/kg diet reduced growth in both sexes to 12 weeks of age compared with the NRC recommended 4000 IU/kg diet. In males, the growth retardation continued to 18 weeks. 4. Vitamin A at 16,000 IU/kg reduced femur development as measured by femur weight to body weight or to femur length ratios.     

The measurement of transplacental magnesium fluxes in the sheep

Bi-directional transport rates of magnesium across the placenta of the ewe have been measured towards the end of pregnancy. The results indicated that approximately 0.042 and Mg/h/kg fetal body weight passed from ewe to fetus and that about 0.012 mg Mg/h/kg fetal body weight was transported back to the ewe. There was a significant, although small, positive gradient in plasma magnesium concentration from ewe to fetus.     

Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows.

OBJECTIVE: To compare pharmacokinetic variables of enrofloxacin (ENR) after IV administration in mice, rats, rabbits, sheep, and cows and to perform allometric analysis of ENR. ANIMALS: 47 mice, 5 rats, 5 rabbits, 5 sheep, and 5 cows. PROCEDURE: Serially obtained plasma samples were assayed for ENR concentration, using high-performance liquid chromatography. In vitro plasma protein binding was determined by ultrafiltration. Plasma ENR concentration versus time curves were fitted by use of nonlinear least-squared regression analysis. Pharmacokinetic variables were correlated further with body weight. RESULTS: In all species studied, the best fit was obtained for a two-compartment open model; ENR half-life ranged from 89 minutes in mice to 169 minutes in cows. Volume of distribution was large in all species studied, with values ranging from 10.5 L/kg in mice to 1.5 L/kg in sheep. Body clearance ranged from 68.1 ml/min/kg for mice to 4.6 ml/min/kg for sheep. Unbound ENR was found to be (mean +/- SD) 58+/-2, 50+/-6, 50+/-2, 31+/-2, and 40+/-3% in plasma of mice, rats, rabbits, sheep, and cows, respectively. The only pharmacokinetic variables that could be correlated with body weight were elimination half-life, clearance, and volume of distribution. Allometric exponents denoting proportionality of half-life, body clearance, and volume of distribution with body weight were 0.06, 0.82, and 0.90, respectively. CONCLUSIONS AND CLINICAL RELEVANCE: An allometric approach could provide a suitable method for determining a scale for ENR pharmacokinetics among various mammalian species. This would faciliatate the administration of appropriate doses of ENR to all animals.